Comparison

Anti-Kv2.1 K+ Channel (External) Antibody

Item no. 75-159
Manufacturer Antibodies Incorporated
Amount 100 uL
Category
Type Antibody Monoclonal
Format Liquid
Applications WB, IHC, ICC
Clone K39/25
Specific against Human (Homo sapiens), Mouse (Murine, Mus musculus), Rat (Rattus norvegicus)
Host Mouse
Isotype IgG2a
Conjugate/Tag Unconjugated
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Alias Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (h-DRK1) (Voltage-gated potassium channel subunit Kv2.1)
Shipping Condition Cool pack
Available
Manufacturer - Type
Primary Antibody
Manufacturer - Targets
Kv2.1 K+ channel (external)
Country of Origin
United States
Shipping Temperature
Shipped on ice packs
Storage Conditions
Aliquot and store at ≤ -20°C for long term storage. For short term storage, store at 2-8°C. For maximum recovery of product, centrifuge the vial prior to removing the cap.
Molecular Weight
105-125 kDa (varies with cell background due to phosphorylation)
Manufacturer - Research Area
Ion Channels and Modulators, K+ Channels
Expiration
24 months from date of receipt
Immunogen
Synthetic peptide amino acids 211-229 (LPELQSLDEFGQSTDNPQL, extracellular S1-S2 loop) of rat Kv2.1 (accession number NP_037318)
Immunogen Species
Rat
Description
Our Anti-Kv2.1 K+ channel (external) mouse monoclonal primary antibody from NeuroMab is produced in-house from hybridoma clone K39/25. It detects human, mouse, and rat Kv2.1 K+ channel (external), and is purified by Protein A chromatography. It is great for use in IHC, ICC, WB.
Target Description
Potassium voltage-gated channel subfamily B member 1 is encoded by the gene KCNB1. KCNB1 is a member of the potassium channel family, B (Shab) (TC 1.A.1.2) subfamily, Kv2.1/KCNB1 sub-subfamily. KCNB1 is a delayed rectifier potassium channel that mediates transmembrane potassium transport. KCNB1 contributes to the regulation of action potential (AP) repolarization, duration and frequency of repetitive AP firing in neurons, muscle cells, and endocrine cells, and plays a role in homeostatic attenuation of electrical excitability throughout the brain. KCNB1 is expressed in the brain, heart, lung, liver, colon, kidney, and adrenal gland. Diseases associated with KCNB1 include early infantile epileptic encephalopathy 26, undetermined early-onset epileptic encephalopathy, visual epilepsy, and alacrima, achalasia, and mental retardation syndrome.
Clonality
Monoclonal
Manufacturer - Specificity
No cross-reactivity reported
Concentration
1 mg/mL
Form
Purified by Protein A chromatography
Buffer
10 mM Tris, 50 mM Sodium Chloride, 0.065% Sodium Azide pH 7.85
Production Notes
Produced by in vitro bioreactor culture of hybridoma line followed by Protein A affinity chromatography. Purified mAbs are >90% specific antibody.
Quality Control
Each new lot of antibody is quality control tested by western blot on rat whole brain lysate and confirmed to stain the expected molecular weight band.
Quality Control: Application
WB Brain
Usage Statement
These antibodies are to be used as research laboratory reagents and are not for use as diagnostic or therapeutic reagents in humans.
Manufacturer - Statement
We produce our Kv2.1 K+ channel (external) mouse monoclonal primary antibody from hybridoma clone K39/25. It is great in IHC, ICC, WB and is purified by Protein A chromatography.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 uL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close